| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.51▼ | 5.51▼ | 5.51▼ | 5.45▼ | 5.61▼ |
| MA10 | 5.91▼ | 5.92▼ | 5.92▼ | 5.64▼ | 6.07▼ |
| MA20 | 6.30▼ | 6.34▼ | 6.34▼ | 5.81▼ | N/A |
| MA50 | 6.71▼ | N/A | N/A | 6.53▼ | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | 1.852▼ | 1.852▼ | 1.852▼ | 5.548▼ | N/A |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -89.728▼ | -96.503▼ |
| CCI | -122.672▼ | -121.607▼ | -121.607▼ | -79.425 | -100.593▼ |
|
Wednesday, May 22, 2019 07:11 AM
CAMBRIDGE, Mass., May22, 2019(GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) ('Anchiano'), a pivotal-stage biopharmaceutical company focused on the discovery and development ...
|
|
Wednesday, May 22, 2019 06:06 AM
“We are pleased with the progress we have made this quarter as a company, with the continued development of inodiftagene, our gene therapy for bladder cancer; our U.S. IPO and Nasdaq listing; and the ...
|
|
Tuesday, May 21, 2019 12:16 AM
Accenture (NYSE: ACN) has opened an Industry X.0 Innovation Center in Essen, Germany, to help resources companies in the chemicals, metals, mining, utilities, and energy industries develop innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/05/19 | 5.5683 | 5.5683 | 5.3768 | 5.4399 | 1,502 |
| 20/05/19 | 5.30 | 5.30 | 5.30 | 5.30 | 0 |
| 17/05/19 | 5.49 | 5.49 | 5.49 | 5.49 | 4,530 |
| 15/05/19 | 5.36 | 5.36 | 5.36 | 5.36 | 521 |
| 14/05/19 | 5.5677 | 5.6623 | 5.54 | 5.6488 | 3,860 |
| 09/05/19 | 5.66 | 5.66 | 5.52 | 5.54 | 3,147 |
| 08/05/19 | 5.95 | 5.95 | 5.60 | 5.9219 | 3,115 |
| 03/05/19 | 5.60 | 6.6619 | 5.60 | 5.73 | 3,883 |
| 02/05/19 | 5.972 | 5.996 | 5.972 | 5.996 | 213 |
| 01/05/19 | 5.73 | 6.1719 | 5.62 | 6.00 | 2,137 |
|
|
||||
|
|
||||
|
|